Anna Pous
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
-
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 1
- COVID-19 and healthcare impacts 1
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 1
- Co-authors
- Eudald Felip (4 shared papers)Laura Layos (1 shared paper)Mireia Margelí Vila (2 shared papers)Cristina Bugés (1 shared paper)Cinta Hierro (1 shared paper)Xavier Guell (1 shared paper)Teresa Morán (3 shared papers)Clara Pretus (1 shared paper)
- Journals
- Cancers (2 papers)Therapeutic Advances in Medical Oncology (1 paper)Comprehensive Psychiatry (1 paper)Translational Lung Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- Spain
In The Last Decade
Anna Pous
6 papers receiving 68 citations
Peers
Comparison fields: 5 of 28
- Oncology 30
- Pulmonary and Respiratory Medicine 13
- Gastroenterology 2
- Psychiatry and Mental health 5
- Computational Theory and Mathematics 6
Countries citing papers authored by Anna Pous
This map shows the geographic impact of Anna Pous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Pous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Pous more than expected).
Fields of papers citing papers by Anna Pous
This network shows the impact of papers produced by Anna Pous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Pous. The network helps show where Anna Pous may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Pous, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 27 | |
| 2 | 2023 | 25 | |
| 3 | 2018 | 7 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 3 | |
| 6 | 2022 | 1 | |
| 7 | 2024 | 0 |
About Anna Pous
Anna Pous is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 7 papers that have together received 68 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (1 paper), Lung Cancer Research Studies (1 paper), COVID-19 and healthcare impacts (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Oncology (30 citations), Pulmonary and Respiratory Medicine (13 citations), Gastroenterology (2 citations), Psychiatry and Mental health (5 citations) and Computational Theory and Mathematics (6 citations). Anna Pous has collaborated with scholars based in Spain. Frequent co-authors include Eudald Felip, Laura Layos, Mireia Margelí Vila, Cristina Bugés, Cinta Hierro, Xavier Guell, Teresa Morán, Clara Pretus, Víctor Pérez and Óscar Vilarroya. Their work appears in journals such as Cancers, Therapeutic Advances in Medical Oncology, Comprehensive Psychiatry, Translational Lung Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.